Candesant Biomedical, Incorporated

Developing a product to selectively target the glands and ducts that produce sweat; it will address the $1.6B under-served hyperhidrosis/sweat control market

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location San Francisco, CA, US
  • Currency USD
  • Founded September 2015
  • Employees 3
  • Incorporation Type C-corp
  • Website candesant.com

Company Summary

"No Sweat" in Just Three Minutes
Candesant Biomedical had developed CDX-101 -- a non-invasive topical treatment that significantly reduces sweat for at least six weeks after a single, 3-minute, no down-time procedure.

Team

  • Niquette Hunt
    CEO, Co-Founder

    25+ years’ experience in developing, launching and commercializing 20+ products across multiple verticals in consumer medicine. Ms. Hunt has proven her ability to drive significant growth on a variety of businesses across multiple industries. Every business she managed increased sales, profits and/or market share. Ms. Hunt has been successful at both large corporations (including P&G and Warner-Lambert) and small start-up companies.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free